Receptors for Advanced Glycation Endproducts and Markers of Systemic Inflammation in Non-Alcoholic Fatty Liver Disease (NAFLD)

被引：0
|
作者：
Mehta, Rohini
Birerdinc, Aybike
Doyle, Katherine
Keaton, Maria
Srishord, Indie
McLaughlin, Leo
Jeffers, Thomas
Felix, Sean
Goodman, Zachary
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)33679-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1665
引用
收藏
页码：S1090 / S1090
页数：1
相关论文
共 50 条
  • [41] Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease
    Rakha, Emad A.
    Adamson, Louise
    Bell, Emily
    Neal, Keith
    Ryder, Stephen D.
    Kaye, Philip V.
    Aithal, Guruprasad P.
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (09) : 790 - 795
  • [42] SARCOPENIA AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH ADVANCED FIBROSIS
    Golabi, Pegah
    Paik, James M.
    Cable, Rebecca
    Racila, Andrei
    Srishord, Manirath
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 1039A - 1039A
  • [43] Non-alcoholic fatty liver disease: A sign of systemic disease
    Reccia, Isabella
    Kumar, Jayant
    Akladios, Cherif
    Virdis, Francesco
    Pai, Madhava
    Habib, Nagy
    Spalding, Duncan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 72 : 94 - 108
  • [44] Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
    Fernando, Dinali H.
    Forbes, Josephine M.
    Angus, Peter W.
    Herath, Chandana B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [45] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [46] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [47] Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
    Leung, Christopher
    Herath, Chandana B.
    Jia, Zhiyuan
    Andrikopoulos, Sof
    Brown, Bronwyn E.
    Davies, Michael J.
    Rivera, Leni R.
    Furness, John B.
    Forbes, Josephine M.
    Angus, Peter W.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (35) : 8026 - 8040
  • [48] Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
    Christopher Leung
    Chandana B Herath
    Zhiyuan Jia
    Sof Andrikopoulos
    Bronwyn E Brown
    Michael J Davies
    Leni R Rivera
    John B Furness
    Josephine M Forbes
    Peter W Angus
    World Journal of Gastroenterology, 2016, 22 (35) : 8026 - 8040
  • [49] Liver Biopsy and Non-alcoholic Fatty Liver Disease (NAFLD) in Bariatric Patients
    Kanakala, V.
    Chattopadhyay, D.
    Sarkar, R.
    Balupuri, S.
    Small, P. K.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 285 - 285
  • [50] Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
    Shinozaki, Satoshi
    Tahara, Toshiyuki
    Lefor, Alan Kawarai
    Ogura, Masahito
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (03) : 270 - 274
12345